http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9912893-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3db66a602a486437a336c0745779cf05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ea81b76ef70a09c1b6875473c013086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50fb59d95d415fbd86afd9e348a40469 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-78 |
| filingDate | 1998-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3bf89fabcc3a4b4be236d3b01d44191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdf4ec57865aaeaffbfbf07de35bdc34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3bd826ce2589986096d4f82723c847c |
| publicationDate | 1999-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9912893-A1 |
| titleOfInvention | Diagnostic and therapeutic alkylenediamine compounds and process |
| abstract | Diamine compounds useful for treating neurodegenerated diseases characterized by the lack of dopamine neurons activity for imaging the dopamine neurons are provided. The diamine compounds or serotonin are characterized by formula (I), wherein 1, m and n can be the same or different and are an integer of 1 to 6; X, Y and Z can be the same or different and are hydrogen, halo, haloalkyl, alkyl, aryl, (C1-C6)alkoxy, N-alkyl, (C2-C6)acyloxy, N-alkylene, -SH, -SR, wherein R is from the same group as R1 and R2 and can be the same or different than R1 and R2, amino, nitro, cyano, hydroxy, C(=O)OR6, -C(=O)NR5R4, NR3R2, or S(=O)kR1, wherein k is 1 or 2, and R1 to R6 are independently hydrogen or (C1-C6)alkyl; R1 and R2 can be the same or different and are hydrogen, (C1-C6)alkyl, hydroxyalkyl or mercaptoalkyl, -C(=O)OR1, cyano, (C1-C6)alkenyl, (C2-C6)alkynyl, or 1,2,4-oxadiazol-5-yl optionally substituted at the 3-position by W wherein any (C1-C6)alkyl, (C1-C6)alkanoyl, (C2-C6)alkenyl or (C2-C6)alkynyl(C1-C6)alkyl, hydroxy(C1-C6)alkyl or mercapto(C1-C6)alkyl and optionally can be substituted by 1, 2 or 3 Z; W is (C1-C6)alkyl or phenyl, optionally substituted by 1, 2 or 3 Z. ΞΆ is phenyl, naphthyl, thienyl or pyridinyl. |
| priorityDate | 1997-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 155.